Startseite UR
![]() | Eine Stufe nach oben |
Ben Hamza, Amin, Welters, Carlotta, Stadler, Serena, Brüggemann, Monika, Dietze, Kerstin, Brauns, Olaf, Brümmendorf, Tim H., Winkler, Thomas W.
, Bullinger, Lars, Blankenstein, Thomas, Rosenberger, Leonie, Leisegang, Matthias, Kammertöns, Thomas, Herr, Wolfgang, Moosmann, Andreas, Strobel, Julian, Hackstein, Holger, Dornmair, Klaus, Beier, Fabian und Hansmann, Leo
(2024)
Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry.
Blood 143 (14), S. 1365-1378.
Welters, Marthe‐Lina, Stadler, Serena, Anastasopoulou, Vasiliki, Bullinger, Lars, Leisegang, Matthias, Kammertöns, Thomas, Welters, Carlotta und Hansmann, Leo
(2024)
Oligonucleotide library screening for identification of virus‐specific T‐cell receptors.
European Journal of Immunology.
Welters, Carlotta, Welters, Marthe-Lina, Stadler, Serena, Bullinger, Lars, Strobel, Julian, Hackstein, Holger, Dhamodaran, Arunraj, Blankenstein, Thomas und Hansmann, Leo
(2023)
HLA-C*04:09N is expressed at the cell surface and triggers peptide-specific T-cell activation.
Haematologica.
, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Hau, Peter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh
, Brehmer, Stefanie, Bullinger, Lars, Galldiks, Norbert
, Schaub, Christina, Kebir, Sied, Stummer, Walter, Simon, Matthias, Fimmers, Rolf, Coch, Christoph, Glas, Martin, Herrlinger, Ulrich und Schäfer, Niklas
(2019)
Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
The Lancet Oncology 20 (10), S. 1444-1453.
Volltext nicht vorhanden.
, Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh
, Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert
, Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes
, Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang
, Weller, Michael
, Fimmers, Rolf, Schmid, Matthias
, Hattingen, Elke
, Pietsch, Torsten, Coch, Christoph und Glas, Martin
(2019)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial.
The Lancet 393 (10172), S. 678-688.
Volltext nicht vorhanden.
, Andrulis, Mindaugas, Lier, Amelie, Milsom, Michael D, Witte, Tania, Gu, Lei, Kim-Wanner, Soo-Zin, Schirmacher, Peter, Wulfert, Michael, Gattermann, Norbert, Lübbert, Michael, Rosenbauer, Frank
, Rehli, Michael, Bullinger, Lars, Weichenhan, Dieter und Plass, Christoph
(2014)
Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia.
Genome Medicine 6 (4).
Volltext nicht vorhanden.
, Corbacioglu, Selim und Debatin, Klaus-Michael
(2014)
Transitory dasatinib-resistant states in KITmut t(8;21) acute myeloid leukemia cells correlate with altered KIT expression.
Experimental Hematology 42 (2), S. 90-100.
Volltext nicht vorhanden.
, Scharfenberger-Schmeer, Maren, Mauch, Julian, Kelkenberg-Schade, Sabine, Haldemann, Berit, Fries, Tamara, Krönke, Jan, Kühn, Michael W. M., Paschka, Peter, Kayser, Sabine, Wolf, Stephan, Gaidzik, Verena I., Schlenk, Richard F., Rücker, Frank G., Döhner, Hartmut, Lottaz, Claudio, Döhner, Konstanze und Bullinger, Lars
(2012)
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing.
Blood 120 (18), e83-e92.
Volltext nicht vorhanden.
Publikationsserver
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707